Advertisement
Cyborg has revealed the substance behind her positive test. AP/Press Association Images
drugs are bad

Cyborg reveals the drug she tested positive for but insists she wasn't doping

Justino says she used spironolactone to counter the effects of extreme weight cutting.

CRIS ‘CYBORG’ JUSTINO has released a statement admitting to a positive USADA drug test but claims that it wasn’t a doping violation.

Cyborg says she failed a drugs test on 5 December and, in a statement on her website, revealed the banned substance to be spironolactone.

More commonly known as Aldactone, spironolactone is primarily used to treat fluid build-up following heart failure or kidney disease.

However, it is also a diuretic and is on the USADA banned list because it can be used to mask performance enhancing drugs.

In her statement, Cyborg said:

“The substance is part of a therapeutic treatment being administered to me by a doctor that started 26 September and is supposed to last for a period of no less than 90 days, requiring blood exams at the completion.

“In addition to the treatment administered to me by Dr Ulyssea M Da C O Pinto (CRM-PR19062/CRM-RJ 30150-9/CRM SC 2740/ CRM -RO 2630) I was given a medical suspension by her not to enter into competition style training or weight cutting practices during the period of recovery.”

The 31-year-old went on to state that her GP administered the drug to counter the effects of extreme weight cutting and she hoped that her positive test would bring attention to the dangers of trying to make weight.

“I cut weight three times in eight months during 2016 competing twice at 140lbs.

“It is because of the measures needed to make the required 140lbs weight limit 24 September that my body is needing the ongoing medical treatment.”

Recognition of MMA in Ireland, mandatory brain scans for SBG and what’s next for McGregor

UFC star Cristiane ‘Cyborg’ Justino gets potential Anti-Doping Policy violation

Your Voice
Readers Comments
9
    Submit a report
    Please help us understand how this comment violates our community guidelines.
    Thank you for the feedback
    Your feedback has been sent to our team for review.